# US 2012/0252046 A1 · Transdermal systems, devices, and methods for biological analysis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252046 A1
- Document ID: US20120252046A1
- Status: Published application
- Kind: A1
- Application number: 13/515,715
- Filed: 2010-12-16
- Published: 2012-10-04
- Earliest claimed: 2009-12-17
- Assignees: Bayer HealthCare LLC
- Inventors: Jiangfeng Fei; Narasinha Parasnis; Swetha Chinnayelka
- Web page: https://patentgrep.com/patent/US20120252046A1

## CPC

- A61B 5/145: Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value {; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue} (non-radiation detecting or locating of foreign bodies in blood A61B5/06)
- A61B 5/14514: {using means for aiding extraction of interstitial fluid, e.g. microneedles or suction}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes}
- A61B 5/1468: using chemical or electrochemical methods, e.g. by polarographic means
- A61B 5/1477: non-invasive
- A61B 5/1486: using enzyme electrodes, e.g. with immobilised oxidase
- A61B 10/0045: {Devices for taking samples of body liquids}
- A61B 2010/008: {Interstitial fluid}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A transdermal test sensor includes a test chamber including a liquid, a reagent system in contact with the liquid, a housing containing the liquid, and a semipermeable membrane. The housing includes an opening, the semipermeable membrane is connected to the housing and covers the opening, and the housing and the semipermeable membrane enclose the liquid and the reagent system. The transdermal test sensor also includes an analyzer in communication with the liquid. When porated tissue is contacted with the semipermeable membrane and sufficient time is allowed for a fluid sample to traverse the porated tissue and for an analyte in the fluid sample to enter the liquid in the transdermal sensor through the semipermeable membrane, a change in at least one optical property or at least one electrical property of the liquid is detected. The change detected is then correlated with the analyte concentration in the fluid sample.

## Claims

### Claim 1

(canceled)

### Claim 2

(canceled)

### Claim 3

(canceled)

### Claim 4

(canceled)

### Claim 5

(canceled)

### Claim 6

(canceled)

### Claim 7

(canceled)

### Claim 8

(canceled)

### Claim 9

(canceled)

### Claim 10

(canceled)

### Claim 11

(canceled)

### Claim 12

(canceled)

### Claim 13

(canceled)

### Claim 14

(canceled)

### Claim 15

(canceled)

### Claim 16

(canceled)

### Claim 17

A method for determining a concentration of at least one analyte in a fluid, comprising:
contacting porated tissue with a semipermeable membrane of a transdermal sensor,
allowing sufficient time for a fluid sample to traverse the porated tissue and for an analyte in the fluid sample to enter a liquid in the transdermal sensor through the semipermeable membrane,
detecting a change in at least one optical property or at least one electrical property of the liquid, and
correlating the change in the at least one optical property or at least one electrical property of the liquid with the concentration of the at least one analyte in the fluid sample.

### Claim 18 (depends on 17)

The method of claim 17, where the liquid comprises water, and the amount of water in the liquid decreases by a first percentage when the semipermeable membrane is in contact with porated tissue for 12 hours;
where, when a comparable transdermal sensor, in which the liquid and semipermeable membrane are replaced with a hydrogel comprising water, is in contact with porated tissue for 12 hours, the amount of water in the hydrogel decreases by a second percentage, and
the second percentage is at least 5 times greater than the first percentage.

### Claim 19 (depends on 18)

The method of claim 18, where the second percentage is at least 10 times greater than the first percentage.

### Claim 20 (depends on 17)

The method of claim 17, where the at least one analyte comprises glucose, and the transdermal sensor has a first glucose sensitivity;
where, when the method is performed with a comparable transdermal sensor, in which the liquid and semipermeable membrane are replaced with a hydrogel, the comparable transdermal sensor has a second glucose sensitivity, and
the first glucose sensitivity is at least 20% greater than the second glucose sensitivity.

### Claim 21 (depends on 20)

The method of claim 20, where the first glucose sensitivity is at least 30% greater than the second glucose sensitivity.

### Claim 22 (depends on 17)

The method of claim 17, where the analyte is glucose, and the transdermal sensor has a first response time;
where, when the method is performed with a comparable transdermal sensor, in which the liquid and semipermeable membrane are replaced with a hydrogel, the comparable transdermal sensor has a second response time, and
the first response time is at least 50% shorter than the second response time.

### Claim 23 (depends on 17)

The method of claim 17, where the analyte is glucose, and the transdermal sensor has a first time for producing 90% of a maximum response;
where, when the method is performed with a comparable transdermal sensor, in which the liquid and semipermeable membrane are replaced with a hydrogel, the comparable transdermal sensor has a second time for producing 90% of a maximum response, and
the first time is at least 2 minutes shorter than the second time.

### Claim 24 (depends on 17)

The method of claim 17, where the liquid comprises a first amount of an enzyme, and the transdermal sensor has a first glucose sensitivity;
where, when the method is performed with a comparable transdermal sensor, in which the liquid and semipermeable membrane are replaced with a hydrogel comprising a second amount of the enzyme, and the comparable transdermal sensor has a second glucose sensitivity less than the first glucose sensitivity,
the first amount of the enzyme is at least 10 times less than the second amount of the enzyme.

### Claim 25 (depends on 17)

The method of claim 17, where the liquid comprises a first amount of an enzyme, and the transdermal sensor has a first response time;
where, when the method is performed with a comparable transdermal sensor, in which the liquid and semipermeable membrane are replaced with a hydrogel comprising a second amount of the enzyme, and the comparable transdermal sensor has a second response time longer than the first response time,
the first amount of the enzyme is at least 10 times less than the second amount of the enzyme.

### Claim 26 (depends on 17)

The method of claim 17, where the liquid comprises a first amount of an enzyme, and the transdermal sensor has a first time for producing 90% of a maximum response;
where, when the method is performed with a comparable transdermal sensor, in which the liquid and semipermeable membrane are replaced with a hydrogel comprising a second amount of the enzyme, and the comparable transdermal sensor has a second time for producing 90% of a maximum response longer than the first time for producing 90% of a maximum response,
the first amount of the enzyme is at least 10 times less than the second amount of the enzyme.

### Claim 27 (depends on 17)

The method of claim 17, further comprising porating tissue.

### Claim 28 (depends on 17)

The method of claim 17, where the detecting a change comprises applying a test excitation signal to the liquid.

### Claim 29 (depends on 17)

The method of claim 17, where the detecting a change comprises applying an excitation electromagnetic radiation beam to the liquid.

### Claim 30 (depends on 17)

The method of claim 17, further comprising outputting the value of the concentration of the at least one analyte to a display.

### Claim 31 (depends on 17)

The method of claim 17, further comprising storing the value of the concentration of the at least one analyte in a storage medium.

### Claim 32

A transdermal test sensor, comprising:
a test chamber comprising a liquid, a reagent system in contact with the liquid, a housing containing the liquid, and a semipermeable membrane,
where the housing comprises an opening,
the semipermeable membrane is connected to the housing and covers the opening,
the housing and the semipermeable membrane enclose the liquid and the reagent system, and
the semipermeable membrane comprises a hydrophilic surface and a maximum pore diameter of 10 to 50 nm; and
an analyzer in communication with the liquid.

### Claim 33

(canceled)

### Claim 34

(canceled)

### Claim 35

(canceled)

### Claim 36

(canceled)

### Claim 37

(canceled)

### Claim 38

(canceled)

### Claim 39

(canceled)

### Claim 40

(canceled)

### Claim 41

(canceled)

### Claim 42

(canceled)

### Claim 43

(canceled)

### Claim 44

(canceled)

### Claim 45

(canceled)

### Claim 46

(canceled)

### Claim 47

(canceled)

### Claim 48

(canceled)

### Claim 49

(canceled)

### Claim 50

(canceled)

### Claim 51

(canceled)

### Claim 52

(canceled)

### Claim 53

(canceled)

### Claim 54

(canceled)

### Claim 55

(canceled)

### Claim 56

(canceled)

### Claim 57

(canceled)

### Claim 58

(canceled)

### Claim 59

(canceled)

### Claim 60

(canceled)

### Claim 61

(canceled)

### Claim 62

(canceled)

### Claim 63

(canceled)

### Claim 64

(canceled)

### Claim 65

(canceled)

### Claim 66

(canceled)

### Claim 67

A transdermal analysis system, comprising:
means for contacting porated tissue with a semipermeable membrane of a transdermal sensor,
means for allowing a fluid sample to traverse the porated tissue and enter a liquid in the transdermal sensor through the semipermeable membrane,
means for detecting a change in at least one optical property or at least one electrical property of the liquid, and
means for correlating the change in the at least one optical property or at least one electrical property of the liquid with the concentration of the at least one analyte in the fluid sample.
